Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Metropolitan Bank Holding Corp. reported net income of $19.2 million for Q2 2026, down from $31.4 million in Q1 2026 but up slightly from $18.8 million in Q2 2025.
Telix dosed the first patient in its Phase 3 LUTEON trial for TLX250-Tx, a radiopharmaceutical therapy targeting relapsed or recurrent clear cell renal cell carcinoma (ccRCC).
